Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

769 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: The FGM-Japan study.
Sakane N, Hirota Y, Yamamoto A, Miura J, Takaike H, Hoshina S, Toyoda M, Saito N, Hosoda K, Matsubara M, Tone A, Kawashima S, Sawaki H, Matsuda T, Domichi M, Suganuma A, Sakane S, Murata T. Sakane N, et al. Among authors: matsubara m. J Diabetes Investig. 2023 Apr;14(4):582-590. doi: 10.1111/jdi.13973. Epub 2023 Feb 14. J Diabetes Investig. 2023. PMID: 36789495 Free PMC article.
To Use or Not to Use a Self-monitoring of Blood Glucose System? Real-world Flash Glucose Monitoring Patterns Using a Cluster Analysis of the FGM-Japan Study.
Sakane N, Hirota Y, Yamamoto A, Miura J, Takaike H, Hoshina S, Toyoda M, Saito N, Hosoda K, Matsubara M, Tone A, Kawashima S, Sawaki H, Matsuda T, Domichi M, Suganuma A, Sakane S, Murata T. Sakane N, et al. Among authors: matsubara m. Intern Med. 2023 Sep 15;62(18):2607-2615. doi: 10.2169/internalmedicine.0639-22. Epub 2023 Jan 12. Intern Med. 2023. PMID: 36631091 Free PMC article.
The effect of continuous glucose monitoring-guided glycemic control on progression of coronary atherosclerosis in type 2 diabetic patients with coronary artery disease: The OPTIMAL randomized clinical trial.
Kataoka Y, Kitahara S, Funabashi S, Makino H, Matsubara M, Matsuo M, Omura-Ohata Y, Koezuka R, Tochiya M, Tamanaha T, Tomita T, Honda-Kohmo K, Noguchi M, Maruki M, Kanai E, Murai K, Iwai T, Sawada K, Matama H, Honda S, Fujino M, Yoneda S, Takagi K, Otsuka F, Asaumi Y, Hosoda K, Nicholls SJ, Yasuda S, Noguchi T. Kataoka Y, et al. Among authors: matsubara m. J Diabetes Complications. 2023 Oct;37(10):108592. doi: 10.1016/j.jdiacomp.2023.108592. Epub 2023 Aug 23. J Diabetes Complications. 2023. PMID: 37741088 Free article. Clinical Trial.
Association of scan frequency with CGM-derived metrics and influential factors in adults with type 1 diabetes mellitus.
Sakane N, Hirota Y, Yamamoto A, Miura J, Takaike H, Hoshina S, Toyoda M, Saito N, Hosoda K, Matsubara M, Tone A, Kawashima S, Sawaki H, Matsuda T, Domichi M, Suganuma A, Sakane S, Murata T. Sakane N, et al. Among authors: matsubara m. Diabetol Int. 2023 Sep 12;15(1):109-116. doi: 10.1007/s13340-023-00655-9. eCollection 2024 Jan. Diabetol Int. 2023. PMID: 38264231
Effect of Luseogliflozin on Myocardial Flow Reserve in Patients with Type 2 Diabetes Mellitus (LUCENT-J Study).
Tamanaha T, Makino H, Son C, Koezuka R, Tochiya M, Omura-Ohata Y, Takekawa T, Matsubara M, Noguchi M, Tomita T, Honda-Kohmo K, Matsuo M, Tateishi E, Fukuda T, Miyamoto Y, Yasuda S, Hosoda K. Tamanaha T, et al. Among authors: matsubara m. Diabetes Ther. 2024 May;15(5):1245-1254. doi: 10.1007/s13300-024-01571-0. Epub 2024 Apr 4. Diabetes Ther. 2024. PMID: 38573468 Free PMC article.
Glucagon-like Peptide-1 analogues and delipidation of coronary atheroma in statin-treated type 2 diabetic patients with coronary artery disease: The prespecified sub-analysis of the OPTIMAL randomized clinical trial.
Kataoka Y, Kitahara S, Funabashi S, Makino H, Matsubara M, Matsuo M, Omura-Ohata Y, Koezuka R, Tochiya M, Tamanaha T, Tomita T, Honda-Kohmo K, Noguchi M, Murai K, Sawada K, Iwai T, Matama H, Honda S, Fujino M, Nakao K, Yoneda S, Takagi K, Otsuka F, Asaumi Y, Hosoda K, Nicholls SJ, Yasuda S, Noguchi T. Kataoka Y, et al. Among authors: matsubara m. Atheroscler Plus. 2024 Apr 4;56:1-6. doi: 10.1016/j.athplu.2024.03.001. eCollection 2024 Jun. Atheroscler Plus. 2024. PMID: 38617596 Free PMC article.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
769 results